pyridostigmine sustained-release tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pyridostigmine sustained-release tablet, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants [Phase 1]